Related Experiment Videos

Comparison of a water-soluble and a water-insoluble podophyllotoxin derivative in murine neoplasms

W Kreis, A Soricelli

    Journal of Cancer Research and Clinical Oncology
    |January 1, 1979
    PubMed

    Insights

    VP-16-213, a water-insoluble podophyllotoxin derivative, showed slight therapeutic superiority and greater toxicity than the water-soluble 27-487 in murine tumors. Both compounds effectively treated Taper liver tumors, suggesting potential for human hepatoma treatment.

    Area of Science:

    • Oncology
    • Pharmacology
    • Cancer Research

    Background:

    • Podophyllotoxin derivatives are investigated for anticancer properties.
    • Water-soluble and water-insoluble formulations may exhibit different efficacy and toxicity profiles.

    Purpose of the Study:

    • To compare the therapeutic efficacy and toxicity of a water-soluble (27-487) and a water-insoluble (VP-16-213) podophyllotoxin derivative.
    • To evaluate the potential of these compounds in treating murine neoplasms, including liver tumors.

    Main Methods:

    • Comparative study of two podophyllotoxin derivatives (27-487 and VP-16-213).
    • In vivo testing in seven different murine tumor models.
    • Assessment of therapeutic response and toxicity.

    Main Results:

    • VP-16-213 demonstrated slight therapeutic superiority over 27-487 across the tested murine neoplasms.
    • VP-16-213 exhibited slightly greater toxicity compared to 27-487.
    • Both compounds showed a significant and positive response in the Taper liver tumor model.

    Conclusions:

    • Podophyllotoxin derivatives, including VP-16-213 and 27-487, show promise in cancer therapy.
    • The Taper liver tumor's response suggests potential utility of these derivatives in treating human hepatomas.
    • Further research into podophyllotoxin derivatives for hepatoma treatment is warranted.

    Related Concept Videos